Latest Articles

Publication Date
M2 Macrophages are Major Mediators of Germline Risk of Endometriosis and Explain Pleiotropy With Comorbid Traits.

Endometriosis is a common gynecologic condition that causes chronic, life-altering symptoms including pain and infertility. There is an urgent need for new non-hormonal targeted therapeutics to treat endometriosis, but until …

Published: Sept. 12, 2025, midnight
United States Endometriosis Therapeutics Market Set for Robust - openPR.com

United States Endometriosis Therapeutics Market Set for Robust openPR.com

Published: Sept. 11, 2025, 9:57 a.m.
Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals - Newser

Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals Newser

Published: Aug. 22, 2025, 6:09 p.m.
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics - Frontiers

Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics Frontiers

Published: Aug. 15, 2025, 1:08 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times

Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire

Published: Aug. 13, 2025, 8:17 p.m.
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView

Karyopharm Therapeutics Inc. SEC 10-Q Report TradingView

Published: Aug. 11, 2025, 11:43 a.m.
Precision Therapeutic and Preventive Molecular Strategies for Endometriosis-Associated Infertility.

Endometriosis, a chronic estrogen-dependent disorder defined by ectopic endometrial-like tissue growth, causes pelvic pain and infertility in reproductive-age women. Despite its prevalence, the underlying mechanisms driving lesion persistence and reproductive …

Published: Aug. 9, 2025, midnight
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest

Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections AInvest

Published: Aug. 8, 2025, 7:14 a.m.
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks

Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks

Published: Aug. 7, 2025, 4:18 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!